The study also evidenced that the combination therapy significantly increased the proportion of both CD4+ and CD8+ T cells in mice lymph nodes and decreased the number of immunosuppressive cells in tumor tissues, including regulatory T cells (Tregs) and myeloid-derived suppressor cells (MDSCs). Here, CD8A is linked to neoplasm.